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Abstract: Mayaro virus (MAYV) is an emerging arthritogenic alphavirus belonging to the Togaviridae
family. Infection leads to a dengue-like illness accompanied by severe polyarthralgia. However,
the molecular and cellular mechanisms of arthritis as a result of MAYV infection remain poorly
understood. In the present study, we assess the susceptibility of human chondrocytes (HC),
fibroblast-like synoviocytes and osteoblasts that are the major cell types involved in osteoarthritis,
to infection with MAYV. We show that these cells are highly permissive to MAYV infection and that
viral RNA copy number and viral titers increase over time in infected cells. Knowing that HC are the
primary cells in articular cartilage and are essential for maintaining the cartilaginous matrix, gene
expression studies were conducted in MAYV-infected primary HC using polymerase chain reaction
(PCR) arrays. The infection of the latter cells resulted in an induction in the expression of several
matrix metalloproteinases (MMP) including MMP1, MMP7, MMP8, MMP10, MMP13, MMP14 and
MMP15 which could be involved in the destruction of articular cartilage. Infected HC were also found
to express significantly increased levels of various IFN-stimulated genes and arthritogenic mediators
such as TNF-α and IL-6. In conclusion, MAYV-infected primary HC overexpress arthritis-related
genes, which may contribute to joint degradation and pathogenesis.
Keywords: arbovirus; Mayaro virus; matrix metalloproteinases; extracellular matrix; chondrocyte;
synoviocyte; osteoblast; innate immunity; IL-6; TNF-α
1. Introduction
Mayaro virus (MAYV) is a little-known emerging mosquito-borne virus of the Togaviridae family
which include Chikungunya (CHIKV), Ross River (RRV), Sindbis and Una viruses. The virus was
first isolated in Trinidad and Tobago in 1954 from the serum of febrile forest patients [1]. MAYV is
phylogenetically related to the Semliki forest antigenic complex and is transmitted by Haemagogus
mosquitoes belonging to the Aedes species, including aegypti, albopictus and scapularis [2]. In the past,
small and occasional outbreaks were reported in the Amazon basin of Brazil, as well as in other areas in
South America [3,4]. Mayaro fever has recently become an important public health problem in Brazil
after several cases of this disease were reported in the region [5]. There have also been recent reports
of Mayaro fever in other areas of South America and Central America [1]. Its recent appearance in
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the Caribbean (Haïti) and the increase of imported cases from South America to other parts of the
world indicate that MAYV may be extending its reach. The MAYV case reported in Haiti may be an
indication that the virus could potentially spread to the southern areas of the United States, especially
due to the increase of immigration and tourism in the area. Both regions also have similar climates
and mosquito vector species that could favor the distribution of the virus. Like other alphaviruses,
such a Ross River virus and Onyong-nyong virus, MAYV consists of a positive single-stranded RNA
of approximately 12 Kb encoding two polyproteins, which consist of four non-structural proteins
(nsP1, nsP2, nsP3, nsP4) and five structural proteins (C, E1, E2, E3, 6k) [2]. Phylogenetic studies that
used whole-genome sequencing have classified MAYV strains into two major genotypes: genotype D,
widely distributed in the Pan-Amazonia, and L, originating from Belterra, Brazil, and a third minor
genotype, N (new), consisting of a single sequence isolated from Peru in 2010 [6]. MAYV causes
a self-limited illness characterized by fever, headache, vomiting, diarrhea, muscle pain, rash and
long-lasting arthralgia—symptoms similar to those induced by other arboviruses such as CHIKV.
Since testing for MAYV is not systematic, the number of cases of patients infected by this virus
may be underestimated. To date, there are no available antiviral drugs or vaccines against MAYV
infection. Because MAYV has received far less attention than other arthritogenic alphaviruses, such
as CHIKV, the pathogenesis of MAYV infection still remains poorly understood. Infection leads to
a dengue-like illness accompanied by severe polyarthralgia [7], however, the molecular and cellular
mechanisms of arthritis due to MAYV remain poorly understood. Moreover, the signaling pathways
and antiviral immune response of the host elicited by this virus remain to be determined. To develop
effective treatments and vaccines, it is important to understand the mechanisms of the host immune
response. Infection by arthritogenic alphaviruses results in severe inflammation in bone, joint and
muscle tissues [8–13]. Several studies describe the persistence of joint pain for months or even years
and indicate that the pathogenesis involved in alphavirus-induced joint damage is determined by
virus persistence and virulence as well as by host immune responses [9,14–18]. It has been reported
that 50% of MAYV infected individuals develop persistent arthralgia affecting the joints [7]. Using
murine models of alphavirus-induced arthritis, cells from musculoskeletal tissues have been described
as targets for alphavirus replication [10,19–21]. The aim of the present study was to analyze whether
the main cells involved in bone and cartilage structure and formation such as human chondrocytes
(HC), fibroblast-like synoviocytes (HFLS) and osteoblasts (HOB) are permissive to MAYV infection.
We also determined the nature of the cellular response induced by MAYV in primary HC which are
responsible for cartilaginous matrix composition and integrity.
2. Materials and Methods
2.1. Virus and Cell Lines
We used the Homo sapiens/Haiti-1/2015 MAYV strain (Genotype L; GenBank accession number
KX496990) [22], a low-passaged strain isolated in 2015 from the plasma of an 8-year-old Haitian child
who had fever and abdominal pain. This strain derived from a reverse genetics system based on its
GenBank sequence. The infectious subgenomic amplicons (ISA) method was used to rescue infectious
viral particles as previously described [23,24]. Briefly, the whole viral genome was de novo synthesized
in three double-stranded overlapping DNA fragments. First and last DNA fragments were flanked
respectively at the 5′ and 3′ termini by the human cytomegalovirus immediate early enhancer/promoter
and the hepatitis delta ribozyme followed by the simian virus 40 polyadenylation signal. These synthetic
DNA fragments were used as template to generate subgenomic amplicons by polymerase chain reaction
(PCR). An equimolar mix of the three purified subgenomic amplicons was used for cell transfection
(HEK-293 cells, Lipofectamine 3000, Thermo Fisher Scientific, Illkirch-Graffenstaden, France). Culture
medium containing infectious cell supernatant was then serially passaged three times in Vero-E6 cells.
This cell line was also used for viral titration and grown in Dulbecco’s modified Eagle’s medium
(DMEM; Invitrogen, Cergy Pontoise, France), supplemented with 5% FCS; Lonza, Basel, Switzerland).
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2.2. Primary Human Cells
Primary HFLS, HOB and HC were obtained from Sigma (Saint Quentin Fallavier, France) and
cultured in synoviocyte growth medium, osteoblast growth medium and chondrocyte growth medium
(Sigma, Saint Quentin Fallavier, France), respectively, at 37 ◦C in a 5% CO2 humidified incubator.
2.3. Infection of Human Fibroblast-Like Synoviocytes (HFLS), Human Osteoblasts (HOB) and Human
Chondrocytes (HC)
Monolayer cultures (2.5 × 105 cells) of each cell types were washed once with Hank’s balanced salt
solution (HBSS) and inoculated with MAYV at a multiplicity of infection (MOI) of 1, at 37 ◦C for 2 h with
gentle agitation. The inoculum was then removed and cells were washed twice with HBSS. One mL of
the corresponding culture medium was added and cells were kept at 37 ◦C in a 5% CO2 atmosphere.
Aliquots of 1 mL of supernatant fluid was harvested at the indicated time points post-infection.
2.4. Virus Titration
The harvested culture supernatants were used in a plaque assay for determination of the efficiency
of viral replication. Briefly, 10-fold dilutions of purified virus were spread onto monolayers of Vero-E6
cells (1.5 × 105 cells/well) in 24-well tissue-culture trays at 37 ◦C for 2 h preceding infection. A mix
of nutriment solution with agar was then added. At 5 days post infection (dpi), the cells were fixed
with 3.7% paraformaldehyde for 15 min and stained with the crystal violet solution in 20% ethanol
(1%) at room temperature for 1 h. Viral titers were calculated by observation of plaque formation.
Mock-infected cells, incubated with the culture supernatant from uninfected C6/36 cells were considered
as controls.
2.5. Quantification of Mayaro Virus (MAYV) by Real-Time Polymerase Chain Reaction (PCR)
According to the manufacturer’s protocol, viral RNA was extracted from infected primary cells by
using Tri reagent (Sigma, Saint Quentin Fallavier, France). The RNA pellet was stored at −80 ◦C after it
was resuspended in 30 µL of RNase-free distilled water. Moloney murine leukemia virus (M-MLV)
reverse transcriptase (Promega, Charbonnieres, France), was used to conduct reverse transcription of
one µg of RNA. Real-time PCR was performed with Maxima probe/ROX quantitative PCR (qPCR)
master mix (Fermentas, Saint Remy les Chevreuses, France). Each 25 µl reaction mixture contained
a final concentration of 500 nM forward primer, 500 nM reverse primer, 250 nM specific probe,
and 1× (final concentration) Maxima probe/ROX qPCR master mix. The quantification of MAYV were
conducted using the following primers and probes: MAYV_F TGCGCCTGCCAGGAGAATGCTGT;
MAYV_R TCGCCTGATGCCTTGGCCAACT; FAM-ACGTACCATTGTGTGTGCCCAAT-BHQ.
MAYV was amplified through activation at 95 ◦C for 10 min followed by 40 amplification cycles
of 95 ◦C for 15 s, 60 ◦C for 30 s, and 72 ◦C for 30 s, using Applied Biosystems 7300 real-time PCR
system. To quantify viral RNA, each sample’s threshold cycle (CT) value was compared with a
MAYV RNA standard curve which was obtained in three steps. First, total viral RNA from the cell
culture was purified using a QIAamp viral RNAkit (Qiagen, Courtaboeuf, France) following the
manufacturer’s protocol. Second, a standard RT-PCR was carried out by using the following primers:
(T7-MAYV_F; TAATACGACTCACTATAGGGTGCGCCTGCCAGGAGAATGCTGT and MAYV_R,
TCGCCTGATGCCTTGGCCAACT) for MAYV. Third, the PCR product was used to generate MAYV
RNA fragments by in vitro transcription using a MAXIscript kit (Ambion, Austin, TX). The RNA
strands generated were determined by spectrophotometry and converted to numbers of molecular
copies by using the following formula: number of y molecules per microliter = [(x grams per microliter
of RNA)/(transcript length in base pairs × 340)] × 6.02 × 1023.
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2.6. RT2 Profiler PCR Array
The RT2 First Strand kit (Qiagen, Valencia, CA, USA) was used for the synthesis of the
complementary DNA strand using 400 µg of total RNA from samples extracted with Tri reagent (Sigma,
Saint Quentin Fallavier, France), following the manufacturer instructions RNA concentrations were
determined using a NanoDrop spectrophotometer. RT2 Profiler™ PCR Array Human Extracellular
Matrix and Adhesion Molecules (PAHS-013Z) and RT2 Profiler™ PCR Array Human Antiviral
Response (PAHS-122Z) were used in the present study. A 384 well plate was used in which each
group of 4 wells contains the primer of a distinct gene. Five housekeeping genes (β-actin (ACTB),
β-2-microglobulin (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine
phosphoribosyltransferase1 (HPRT1) and ribosomal protein, large, P0 (HPLP0) were used as internal
control. The Roche LightCycler 480 real-time cycler was used to amplify the DNA with a thermal
cycling of 95 ◦C for 10 min followed by 40 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min, followed by a
melting curve acquisition step.
Briefly, cDNA reaction mixture (20 µL per sample) was diluted in 91 µL of nuclease-free H2O
(Qiagen), 102 µL aliquot was mixed with 548 µL of RNase free H2O and 650 µL of 2 × RT2 SYBR green
RT2 master mix following the manufacturer’s instructions, and 10 µL of the mix was loaded into each
well. The average of reverse transcription control values and positive PCR control CT values was
used to normalize gene expression and determine fold changes between groups. Changes in mRNA
expression were analyzed using the ∆∆Ct method. The experiments were performed in biological
and technical triplicates with which the confidence level was determined. Target gene Ct values
were normalized with housekeeping genes. Gene modulation was considered statistically significant
at a 95% confidence level (p < 0.05). The confidence level was determined from data obtained in
triplicate for each sample. RT2 profiler RT-PCR array data analysis software (version 3.5) was used for
statistical analysis.
2.7. Gene Expression Analysis by Real-Time PCR
The total RNA 1 µg of Human chondrocyte cells was used to synthesize cDNA using the MMLV
reverse transcription Kit (Promega, Charboniere, France). Real-time PCR was performed using 1 µL of
cDNA with specific primers targeting the genes of interest. For the expression of each gene, a reaction
volume of 9 µL contained a primer concentration of 400 nM and 4 µL of Fast Eva Green Master Mix
(Invitrogen; Thermo Fisher Scientific, Inc.). The cycling conditions were 45 cycles of 95 ◦C for 15 s,
60 ◦C for 15 s, and 72 ◦C for 20 s. The transcript level (fold change) was quantified by calculating the
2−∆∆CT value, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA as an endogenous
control. The primers used in the present study are listed in a Supplementary Table S1.
2.8. Measurements of Cytokines
Concentrations of IL-6 and TNF-α in the culture supernatants of HC were determined using
enzyme-linked immunosorbent assay (ELISA) kits (Quantikine, R&D Systems, Mineapolis, MN,
USA) according to the manufacturer’s instructions. The absorbance at 450 nm was measured using
a microplate reader (Infinite M200PRO TECAN, Männedorf, Switzerland) and concentrations of
cytokines were determined by interpolation of a standard curve.
2.9. Western Blot
Cells were lysed in RIPA buffer (150 mM NaCl, 5 mM β-mercaptoethanol, 1% NP-40, 0.1%
sodium dodecyl sulfate, 50 mM Tris-HCl, pH 8) supplemented with protease and phosphatase
inhibitor cocktail solution (Sigma, Saint Quentin Fallavier, France). The protein concentration was
determined using bicinchoninic acid assay quantification kit (Thermo Scientific, Saint Herblain,
France) following the manufacturer’s procedure. Equal amounts of proteins were mixed with
Laemmli sample buffer and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis
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(SDS-PAGE) and electrotransferred onto a nitrocellulose membrane. The membrane was blocked with
phosphate-buffered saline (PBS) 0.05% Tween 20 containing 5% skim milk and incubated overnight with
primary antibodies. The following primary antibodies were used: anti-Viperin, anti-MMP9 anti-MMP2,
anti-MMP14, and anti-β-actin were obtained from Cell Signaling (Cell Signaling Technology, Inc.,
Danvers, MA, USA). The membranes were washed 3 times with PBS-Tween and incubated for 2 h
at room temperature with horseradish peroxidase-coupled secondary antibodies (Sigma). Proteins
were detected by chemiluminescence using a SuperSignal West Pico chemiluminescent substrate kit
(Thermo Scientific).
2.10. Cell Viability Assay
ReadyProbes®Cell Viability Imaging Kit (Blue/Green) (Thermo Fisher Scientific, Illkirch-Graffenstaden,
France) was used to determine the viability of HC cells following the manufacturer’s recommendation.
Briefly, HC were inoculated with MAYV at the MOI of 1, at 6, 24 and 48 h post-infection (hpi), 2 drops
of NucBlue®Live reagent (Hoechst 33342) and NucGreen®Dead reagent were added into each wells
(2 drops/ mL of cell growth media) at room temperature for 5min. Cell viability was determined
by counting total cells and dead cells: NucBlue®Live reagent stained the nuclei of live cells and
were detected with a DAPI filter; NucGreen®Dead reagent stained the nuclei of dead cells and were
detected with standard GFP (green) filter by fluorescence microscopy using a Leica microscope at
10-fold magnification.
3. Results and Discussion
Severe join pain and stiffness are the hallmark of arthritogenic alphaviruses [25,26]. In order to
determine the permissiveness of primary HC, HOB and HFLS, cells were infected with MAYV at a
multiplicity of infection (MOI) of 1. We first quantified the intracellular viral RNA by real-time PCR at
different hours post-infection (hpi). The amounts of viral transcripts were markedly high in all cell
types reaching 108–109 RNA copies/µg at 48 hpi and could be determined as soon as 6 hpi. The results
show a gradual increase in viral RNA copy numbers during the course of infection (Figure 1A–C).
Next, we evaluated the ability of the infected cells to produce viral progeny by determining viral titers
in the supernatants of MAYV-infected cells, using a plaque assay. The production of viral particles
increases over time, indicating active viral replication in the infected cells (Figure 1D–F). These findings
demonstrate that primary HC, HOB and HFLS are susceptible to MAYV infection. These results are
in accordance with previous studies demonstrating that bone cells can be productively infected by
arthritogenic alphaviruses such as RVV and CHIKV [19,20,27].
Articular cartilage is a tissue mainly composed of chondrocytes, enclosed in an extracellular matrix
(ECM) [28]. These cells are responsible for the synthesis and maintenance of all ECM molecules [28–30],
thereby conferring to cartilage its functions of mechanical support and joint lubrification. In order
to evaluate the impact of MAYV on the expression of genes involved in the composition of the ECM,
primary HC were infected with MAYV, at a MOI of 1, at 24 and 48 hpi and mRNA expression of
84 genes important for cell–cell and cell–matrix interactions were quantified using a specific qPCR
array analysis (Figure 2 and Table S2). The infection of these cells resulted in an early (24 hpi)
upregulation of several matrix metalloproteinases (MMPs) including MMP1, MMP7, MMP8, MMP9,
MMP10, MMP11, MMP13 (Figure 2 and Table S2). Interestingly, a substantial cartilage erosion with
overproduction of matrix degrading enzymes such as MMP9 has previously been reported in the joints
of RRV-infected-mice [31]. Increased level of MMP 9 protein expression was validated by Western
blotting analysis (Figure S2). MMPs play a critical role in the destruction of articular cartilage in
disease processes such as arthritis [32] and, therefore, could contribute to bone degradation during
MAYV infection. The gene expression levels of the Membrane Type 1 MMP (MMP14) and Type 2
MMP (MMP15) were dramatically increase at 24 hpi in MAYV-infected cells, with a fold change of 183
and 10 respectively, as compared to mock-infected cells (Figure 2 and Table S2). These enzymes are
well-documented for their role in pericellular collagenolysis [33]. The expression levels of seven MMPs
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were validated by individual PCR using different primer sets and different chemistry. As expected,
apart from MMP2 expression the transcript levels of MMP1, MMP8, MMP10, MMP13, MMP14 and
MMP15 were upregulated following MAYV infection (Figure S1).Viruses 2019, 11, x FOR PEER REVIEW 6 of 13 
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Figure 1. Human chondrocytes (HC), fibroblast-like synoviocytes (HFLS) and osteoblasts (HOB) are
permissive to Mayaro virus (MAYV) infection. Cells were infected with MAYV at a multiplicity of
infection (MOI) of 1. Viral RNA expression was then measured at 6, 24 and 48 h post-infection using
real-time polymerase chain reaction (PCR) (A–C). Plaque assay analysis of culture supernatants of
MAYV-infected cells were used to detect infectious viral particles (D–F). Experiments were performed
three times each in triplicate (error bars represent standard errors of the means [SEM]). Comparisons
between the indicated time point post infection were performed using one-way analysis of variance
(ANOVA) and Tukey’s multiple comparisons test with a P-value significant when * p < 0.05, ** p < 0.01,
*** p < 0.001, **** p < 0.0001.
Interestingly, genes encoding collagens Col16A1, Col1A1, Col4A2, Col5A1, Col6A1 and Col6A2
were strongly downregulated at 24 hpi. It would be of interest to evaluate whether there is a link
between the overexpression of MMPs transcripts and the subsequent decreased expression of these
ECM structural components. A recent study showed that expression of type I and type II collagen
was downregulated upon infection of HC by RVV [20], corroborating our results. Transcript levels
of the other ECM proteases such as ADAMTS8, ADAMTS13 and SPG7 were also increased in HC
exposed to MAYV (Figure 2 and Supplementary Table S2). CLEC3B has previously been identified as a
gene candidate associated with osteoarthritis (OA) [34,35]. Expression levels of CLEC3B transcripts
was found to be upregulated in MAYV-infected HC. In contrast, gene expression levels of the cell–cell
adhesion molecules ICAM1, ITGA1, ITGAV, ITGB1, and ITGB5 were downregulated at 24 hpi in
infected primary HC (Figure 2 and Supplementary Table S2). These results indicate that MAYV strongly
modulates the gene expression levels of human extracellular matrix and adhesion molecules in the
latter cells. Next, we evaluated whether MAYV induces an innate antiviral immune response in HC.
For this purpose, the antiviral gene expression profile in infected cells were quantified at 24 and
48 hpi using a human qPCR array covering 84 human antiviral genes (Table 1). This comparative
analysis with mock-infected cells showed that the induction of the antiviral response by HC increased
in a time dependent-manner. MAYV induced the transcription of the pattern recognition receptors
TLR3, RIG-I, and MDA5 which are known to recognize several arboviruses [36,37]. The detection
of MAYV by PRRs increased the mRNA expression of the transcription factor IRF7 leading to the
strongly enhanced interferon-β gene expression, as well as several interferon-stimulated genes (ISG),
including ISG15, MX1, OAS2. Individual quantitative RT-PCR analyses also demonstrated that MAYV
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induced, in a dose dependent-manner, the transcript levels of other ISG which have been shown to
exert antiviral effect against CHIKV [38,39]: Viperin, OAS1, and OAS3 (Figure 3). Protein levels of
Viperin were also increased upon exposure of HC with MAYV (Supplementary Figure S2). It was
shown previouly that Viperin is critical for the control of CHIKV infection and joint pathology [40].
In fact, mice lacking Viperin had higher viremia and severe joint inflammation. It would be interesting
to explore whether there is a link between the level of Viperin and expression of ECM components
following MAYV infection.Viruses 2019, 11, x FOR PEER REVIEW 7 of 13 
 
 
Figure 2. Modulation of extracellular matrix genes by MAYV in primary human chondrocytes. 
Human chondrocytes were infected with MAYV at MOI 1. The modulation of extracellular matrix 
and adhesion molecules gene expression was quantified by RT² Profiler PCR arrays at 6 and 24 h post-
infection. The graph represents the most important expressed genes. Gene modulation was 
considered statistically significant at a 95% confidence level (p < 0.05). RT2 profiler real-time PCR (RT-
PCR) array data analysis software (version 3.5) was used for statistical analysis. 
Interestingly, genes encoding collagens Col16A1, Col1A1, Col4A2, Col5A1, Col6A1 and Col6A2 
were strongly downregulated at 24 hpi. It would be of interest to evaluate whether there is a link 
between the overexpression of MMPs transcripts and the subsequent decreased expression of these 
ECM structural components. A recent study showed that expression of type I and type II collagen 
was downregulated upon infection of HC by RVV [20], corroborating our results. Transcript levels 
of the other ECM proteases such as ADAMTS8, ADAMTS13 and SPG7 were also increased in HC 
exposed to MAYV (Figure 2 and Supplementary Table S2). CLEC3B has previously been identified 
as a gene candidate associated with osteoarthritis (OA) [34,35]. Expression levels of CLEC3B 
transcripts was found to be upregulated in MAYV-infected HC. In contrast, gene expression levels of 
the cell–cell adhesion molecules ICAM1, ITGA1, ITGAV, ITGB1, and ITGB5 were downregulated at 
24 hpi in infected primary HC (Figure 2 and Supplementary Table S2). These results indicate that 
MAYV strongly modulates the gene expression levels of human extracellular matrix and adhesion 
molecules in the latter cells. Next, we evaluated whether MAYV induces an innate antiviral immune 
response in HC. For this purpose, the antiviral gene expression profile in infected cells were 
quantified at 24 and 48 hpi using a human qPCR array covering 84 human antiviral genes (Table 1). 
This comparative analysis with mock-infected cells showed that the induction of the antiviral 
response by HC increased in a time dependent-manner. MAYV induced the transcription of the 
pattern recognition receptors TLR3, RIG-I, and MDA5 which are known to recognize several 
arboviruses [36,37]. The detection of MAYV by PRRs increased the mRNA expression of the 
transcription factor IRF7 leading to the strongly enhanced interferon-β gene expression, as well as 
several interferon-stimulated genes (ISG), including ISG15, MX1, OAS2 (Table 2). Individual 
quantitative RT-PCR analyses also demonstrated that MAYV induced, in a dose dependent-manner, 
the transcript levels of other ISG which have been shown to exert antiviral effect against CHIKV 
[38,39]: Viperin, OAS1, and OAS3 (Figure 3). Protein levels of Viperin were also increased upon 
Figure 2. Modulation of extracellular matrix genes by MAYV in primary human chondrocytes. Human
chondrocytes were infected with MAYV at MOI 1. The modulation of extracellular matrix and adhesion
molecules gene expression was quantified by RT2 Profiler PCR arrays at 6 and 24 h post-infection.
The graph represents the most important expressed genes. Gene modulation was considered statistically
significant at a 95% confidence level (p < 0.05). RT2 profiler real-time PCR (RT-PCR) array data analysis
software (version 3.5) was used for statistical analysis.
Table 1. Modulation of antiviral genes by Mayaro virus in primary human chondrocytes.
Fold Change in Gene Expression at
Indicated Time Postinfection a
Fold Change in Gene Expre sion at
Indicated Time Postinfection a
Gene 24 h 48 h Gene 24 h 48 h
AIM2 −1.11 15.85 IRF3 −1.41 −1.14
APOBEC3G 1.37 5.35 IRF5 −1.05 −1.66
ATG5 −1.44 −1.58 IRF7 9.04 24.08
AZI2 −1.93 −2.00 ISG15 30.84 176.88
CARD9 1.38 −1.00 JUN −1.15 1.11
CASP1 1.16 1.90 MAP2K1 1.10 1.08
CASP10 2.31 −1.07 MAP2K3 −1.61 −1.79
CASP8 −1.50 −1.51 MAP3K1 −1.66 −2.44
CCL3 1.87 4.42 MAP3K7 −1.80 −1.78
CCL5 3.79 44.84 MAPK1 −1.64 −1.54
CD40 −1.54 −1.09 M PK14 −1.68 −1.49
CD80 −1.32 −1.73 MAPK3 −1.16 −1.94
CD86 −1.29 −1.00 MAPK8 −1.24 −1.84
CHUK −1.10 1.05 MAVS −1.99 −1.22
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Table 1. Cont.
Fold Change in Gene Expression at
Indicated Time Postinfection a
Fold Change in Gene Expression at
Indicated Time Postinfection a
Gene 24 h 48 h Gene 24 h 48 h
CTSB 1.06 −3.50 MEFV 1.34 −1.52
CTSL1 −1.53 1.06 MX1 36.17 43.51
CTSS −1.3 2.91 MYD88 1.43 2.71
CXCL10 25.28 304.44 NFKB1 1.17 1.39
CXCL11 18,25 242.19 NFKBIA −1.11 2.17
CXCL9 1.25 1.77 NLRP3 2.73 1.03
CYLD −1.49 −1.01 NOD2 1.25 −1.76
DAK −1.12 −1.53 OAS2 13.06 28.18
DDX3X −1.57 −2.05 PIN1 1.24 1.27
DDX58 (RIG–I) 6.68 13.12 PSTPIP1 −1.65 −2.44
DHX58 (LGP2) 2.22 6.42 PYCARD −1.73 −1.58
FADD −1.21 −1.68 PYDC1 1.37 1.22
FOS 15.42 9.00 RELA −1.01 1.41
HSP90AA1 −1.38 −1.03 RIPK1 1.44 2.21
IFIH1 (MDA5) 6.51 16.34 SPP1 −1.49 2.13
IFNA1 1.12 1.55 STAT1 1.84 2.15
IFNA2 3.59 4.79 SUGT1 −1.84 −1.61
IFNAR1 −1.54 −2.11 TBK1 −2.36 −1.65
IFNB1 45.68 570.73 TICAM1 −1.30 1.52
IKBKB −1.26 −1.14 TLR3 1.14 2.51
IL12A −1.64 −1.51 TLR7 1.16 1.03
IL12B −1.24 1.12 TLR8 1.04 1.52
IL15 1.15 1.59 TLR9 −1.39 −1.10
IL18 −2.09 −2.78 TNF ND ND
IL1B 2.02 6.71 TRADD 1.27 1.30
IL6 −2.24 2.24 TRAF3 −1.13 −1.63
IL8 −1.37 6.02 TRAF6 −2.66 −1.77
IRAK1 1.84 −1.16 TRIM25 2.08 1.78
a Values represent fold inductions of mRNA copy numbers in infected cells relative to mock-infected cells. Values in
bold indicate differentially expressed genes. ND: not determined.
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Figure 3. Regulation of immune genes in MAYV-infected human chondrocytes. Primary HC were
exposed to MAYV at a MOI of 1, and mRNA levels of the corresponding genes were quantified by
real-time PCR. Fold change compared to mock-infected cells are shown. Data are representative of three
independent experiments, each performed in triplicate (error bars represent SEM). Differences between
data were analyzed using the Wilcoxon–Mann–Whitney test. p values of < 0.05 were considered
significant (*).
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The data also revealed that mRNA expression of the arthritogenic mediators TNF-α and IL-6 were
significantly increased at 48 hpi (Figure 3). We determined the concentration of IL-6 and TNF-α in
the culture supernatants of MAYV-infected cells and found upregulation of both cytokines at 48 hpi
(Figure 4). Interestingly, it has been shown that these pro-inflammatory cytokines are associated with
OA occurrence and are able to activate the mitogen-activated protein kinase and Janus kinase/signal
transducers and activators of transcription pathways by binding the cytokine to their receptors
on chondrocytes and synoviocytes, leading to increased synthesis of MMPs and ADAMTS [41–43].
A longitudinal study assessing the immune response following MAYV infection showed that TNF-α
remained significantly elevated in patients who developed persistent arthralgia when compared with
healthy donors [13]. IL-6 has been previously identified as predictor of disease severity in longitudinal
studies assessing the inflammatory response following CHIKV infection [44,45]. In agreement with
our results infection of HC by RVV also induces the production of TNF-α and IL-6 [20].
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Figure 4. MAYV increases the production of proinflammatory cytokines in primary human chondrocytes.
IL-6 and TNF-α secretion were quantified i the supernat nt of infected cells using ELISA. Mock-infected
cells were used as control. The data represent three independent experiments, each performed in
triplicate. The two-way ANOVA statistical analysis with Bonferroni’s test was used to analyse the set
of data. *** p < 0.0001.
Finally, we evaluated whether MAYV was able to induce a cytopathic effect in HC. For this
purpose, cells were infected with the virus at a MOI of 1 and cell viability were determined at different
time post-infection by immunofluorescence staining the nuclei of dead cells with compromised plasma
membranes (Figure 5A). Results showed that at 24 and 48 hpi, 8% and 30%, respectively, of cells were
stained in MAYV-infected HC, as compared to mock-infected cells (Figure 5B), thereby demonstrating
the capability of MAYV to induce chondrocyte cell death. Several studies demonstrated that apoptosis
occurred more frequently in cartilage from osteoarthritis patients than in cartilage from healthy
subjects [46] and that there was a positive correlation between the number of apoptotic chondrocytes
and cartilage degradation [42]. Chondrocyte cell death was also linked to the overproduction of matrix
degradative enzymes [47]. Nevertheless, further studies are needed to understand whether cell death
is due to a bystander effect or direct cytopathic effects.
In conclusion, we show that primary HC, HOB and HFLS, the major cell types involved in arthritis,
are permissive to MAYV infection and that HC may play a crucial role in the pathogenesis of the
disease by overexpressing arthritogenic mediators and arthritis-related genes.
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Figure 5. MAYV induces chondrocyte cell death. Primary HC were infected with MAYV at a MOI of 1.
(A) The cell viability was determined at 6, 24 and 48 hpi and visualized with a fluorescence microscope.
NucBlue®Live and NucGreen®Dead reagents were added to cells in full growth media and cell
were visualized under fluorescent microscope. Mock-infected cells were used as control. (B) Median
numbers of dead cells (green fluorescent cells) counted in the fields of view at the indicated time points
post infection. Each dot represents the number of cells counted in one field. Horizontal bars indicate
the median. Comparisons of dead cell numbers were performed using one-way ANOVA (p < 0.0001)
followed by Tukey’s post hoc test for multiple comparisons **** p < 0.0001. The data are representative
of three independent experiments.
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